PRRT2 and type 2 diabetes mellitus: These observations can easily be explained by our model where increase in FA and AA levels (in obese and T2DM) lead to respective increase in PKC, mTOR-S6K1p and subsequent inhibition of IRS and downstream kinases like AKTp.